1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Xyloside-primed chondroitin sulfate/dermatan sulfate from breast carcinoma cells with a defined disaccharide composition has cytotoxic effects in vitro
(
- Contribution to journal › Article
- 2015
-
Mark
Exploration of the active site of β4GalT7: modifications of the aglycon of aromatic xylosides.
(
- Contribution to journal › Article
- 2014
-
Mark
Rules for priming and inhibition of glycosaminoglycan biosynthesis; probing the beta 4GalT7 active site
(
- Contribution to journal › Article
- 2001
-
Mark
Differences in the uptake and nuclear localization of anti-proliferative heparan sulfate between human lung fibroblasts and human lung carcinoma cells
(
- Contribution to journal › Article
- 1998
-
Mark
Heparan/chondroitin/dermatan sulfate primer 2-(6-hydroxynaphthyl)-O-beta-D-xylopyranoside preferentially inhibits growth of transformed cells
(
- Contribution to journal › Article
- 1997
-
Mark
Binding, internalization, and degradation of antiproliferative heparan sulfate by human embryonic lung fibroblasts
(
- Contribution to journal › Article
- 1993
-
Mark
L-iduronate-rich glycosaminoglycans inhibit growth of normal fibroblasts independently of serum or added growth factors
(
- Contribution to journal › Article
- 1992
-
Mark
Transforming growth factor-beta induces selective increase of proteoglycan production and changes in the copolymeric structure of dermatan sulphate in human skin fibroblasts
(
- Contribution to journal › Article
- 1991
-
Mark
Proliferation of cultured fibroblasts is inhibited by L-iduronate-containing glycosaminoglycans
(
- Contribution to journal › Article
- 1990
-
Mark
TGF-beta enhances the production of hyaluronan in human lung but not in skin fibroblasts
(
- Contribution to journal › Article